Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Summary

This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.

Eligibility

Inclusion Criteria:

* Patient is an adult biological male.
* Patient has morphologically confirmed and untreated prostate cancer.
* Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
* Patient is informed about this observational study and has signed the informed consent form.

Exclusion Criteria:

* Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
* Patient received neoadjuvant prostate cancer treatment.
* Patient is set to receive adjuvant treatment.
* Patient has any contraindications for the operation.

Conditions6

Browse More Trials